Physician profile
Mario E Pelletier
NPI 1457310724
$3,053.21
in general payments reported to CMS, 2019-2025
16 companies · $42.65 in 2025
The $42.65 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $470 · 2021: $502 · 2022: $406 · 2023: $888 · 2024: $45.78 · 2025: $42.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,622.68 | 2019-2023 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $673.32 | 2019-2023 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $202.55 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $122.20 | 2019 | |
| Novo Nordisk INC | $92.96 | 2019-2023 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $88.43 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $46.31 | 2019-2021 | |
| Tactile Systems Technology INC | $36.30 | 2019 | |
| Allergan, INC. | $36.11 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $29.20 | 2019 | |
| Ascensia Diabetes Care US INC. | $27.80 | 2019 | |
| Mylan Specialty L.P. | $25.08 | 2019-2020 | |
| Pfizer INC. | $14.20 | 2020 | |
| Ironwood Pharmaceuticals, INC | $13.44 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Pelletier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.